India's position on intellectual property rights and pharmaceutical issues in proposed trade agreements strikes a balance between fostering innovation and addressing public health needs. By resisting pressures from developed nations regarding concepts like 'data exclusivity' and 'patent linkage' in free trade agreements, India facilitates greater market access for generic drug manufacturers, leading to a significant reduction in the cost of …
The government announced on Thursday that it has decided to reject the demand from the four European nations in the European Free Trade Association bloc to include a 'data exclusivity' provision in proposed Free Trade Agreements. Commerce Secretary Sunil Barthwal stated that India will not enter into any FTA that compromises the interests of the generic drug industry. In fact, …
A clause in a draft free trade agreement text being negotiated between India and the European Free Trade Association — Switzerland, Iceland, Lichtenstein and Norway — could delay access to affordable, generic versions of patented drugs in India by a minimum of six years, according to documents viewed by The Hindu. A leaked draft of the Trade and Economic Partnership …
